Clinical Trial Update: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the efficacy and potential mechanism of trientine in patients with hypertrophic cardiomyopathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Trientine (trientine)

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED